Seven Fleet Capital Management LP

Registered adviser

CIK

2092021

Location

MOUNTAIN VIEW, CA

Portfolio Value

Small $610,242,510

Diversification

Diversified

Reports for

DV Trading LLC

Filing Date

Global Rank

#3,416 / 8,818 ▲ 3149

Top Industry

Biotechnology 96.0%

Period ended 4 months ago

Filed Aug 17, 2026 · 2mo

3 quarters · since Dec 2025

Regulatory profile

From Form ADV, the SEC filer profile, 13D/13G type codes and N-CEN, never from the name.

Holder type

Registered adviser

Form ADV roster, Oct 1, 2026

Form ADV adviser

CRD 335203

Roster of Oct 1, 2026

Regulatory AUM

$434,581,362

Main clients

Pooled investment vehicles (100% of AUM)

Private funds

2 funds · Mixed

Focus by fund count, roster of Oct 1, 2026

$434,581,362 gross assets

Stated strategy

Long/short hedge, Fundamental active, Value, Growth, Private markets, Activist Form ADV Part 2A, Jun 30, 2026 · original

In the firm's words

Long/short hedge: The majority of the Client Accounts’ portfolios will include long and short positions of common stock, with options used for risk management or enhancement of returns.
Fundamental active: Seven Fleet brings technical experience in evaluating the fundamentals of therapeutics companies, including an understanding of biology, clinical trial design, biostatistics, regulatory pathways, and competitive dynamics.
Value: Seven Fleet will typically take long positions if Seven Fleet believes that a company has a depressed valuation relative to peers
Growth: In advising the Client Accounts, Seven Fleet will invest in securities of companies in their growth stage.
Private markets: The Client Accounts may from time to time make investments in late growth stage private companies.
Activist: In some cases, the trading program may result in the Client Accounts taking an activist position with respect to an issuer.

Portfolio style

Measured from the filed 13F common-share book for Jun 30, 2026, never from the firm's own description.

Style

Concentrated

The top 10 positions are 65.5% of the book (60%+)

Turnover

Turnover unknown

It needs four straight quarters of measured turnover

Horizon

Short horizon

Value-weighted holding period 2.7 quarters (under 4)

Closest benchmark: the Russell 2000 as of 2026-06-30, active share 95.2%; sector active share 90.8% against the combined 13F book's sector weights.

Over time 3 measured quarters

How the bands are measured

Style bands measure the filed 13F common-share book each closed quarter, tested in this order. Unknown: under $10,000,000 of valued equity or 5 stocks. Index-like (100+ stocks): active share of 20% or less against the closest benchmark, which is the S&P 500, S&P MidCap 400, S&P SmallCap 600, Russell 1000, Russell 2000, Nasdaq-100 or Dow Jones Industrial Average (weighted by an index-tracking fund's reported holdings or the index's constituents nearest the quarter end, over the names resolved to companies, and only when those are 90%+ of its weight) or every 13F filer's combined book, or index series holding 80%+ of the registered fund assets it advises (N-CEN) and equal to 50%+ of its book. Systematic-like: 500+ stocks, 100%+ annual turnover and a top 10 weight of 25% or less. Concentrated: a top 10 weight of 60%+ or 12 or fewer effective positions. Diversified active: none of these. Turnover is the smaller of buys and sells over average equity value, summed over four quarters: low under 30%, high 100%+. Horizon is the value-weighted number of quarters each position has been held: short under 4, long 12+.

Clone Performance

Build a hypothetical price-return history from this filer's public 13F holdings.

View clone backtest

Portfolio Concentration

96 tracked positions · as of Jun 30, 2026 · Δ vs Mar 31, 2026

Top Position

22.0%

+15.8 pts

Top 5

53.7%

+30.3 pts

Top 10

65.5%

+24.4 pts

HHI

902

Diversified+646

Portfolio Trend

3 quarters · across all stocks

Sector Breakdown

As of Jun 30, 2026

Sector	% Portfolio	Value	Positions
Healthcare	99.9%	$609,560,652	95
Unclassified	0.1%	$681,858	1

Last Quarter's Activity

Export CSV

Jun 30, 2026 vs Mar 31, 2026

Added To

Positions the filer increased

25 positions

Ticker	Company	Δ Shares	Shares	Value
TNGX	Tango Therapeutics, Inc.	+2,726,132	3,228,144	$100,911,781
CGON	CG Oncology, Inc.	+1,810,478	1,886,236	$134,017,067
IPSC	Century Therapeutics, Inc.	+1,400,000	4,347,826	$10,652,173
TSHA	Taysha Gene Therapies, Inc.	+878,692	1,504,400	$10,244,964
NERV	Minerva Neurosciences, Inc.	+752,897	1,001,373	$5,557,619
CTMX	CytomX Therapeutics, Inc.	+714,000	1,085,398	$4,070,242
SABS	SAB Biotherapeutics, Inc.	+636,077	736,077	$2,870,700
GERN	Geron Corp	+633,048	1,057,228	$1,353,251
PHVS	Pharvaris N.V.	+601,770	774,501	$26,782,243
AVTX	Avalo Therapeutics, Inc.	+556,946	770,765	$14,243,736
ASMB	Assembly Biosciences, Inc.	+377,000	433,147	$11,902,879
CCCC	C4 Therapeutics, Inc.	+324,093	381,169	$1,780,059
XNCR	Xencor Inc	+288,305	368,305	$5,929,710
ZNTL	Zentalis Pharmaceuticals, Inc.	+207,600	317,600	$1,540,360
ELVN	Enliven Therapeutics, Inc.	+201,356	365,386	$18,543,339
AVBP	ArriVent BioPharma, Inc.	+196,354	246,606	$8,567,092
DMRA	Damora Therapeutics, Inc.	+183,182	284,430	$7,398,024
EPRX	Eupraxia Pharmaceuticals Inc.	+177,270	610,785	$4,037,288
RVMD	Revolution Medicines, Inc.	+161,237	242,029	$45,327,190
VYGR	Voyager Therapeutics, Inc.	+115,203	230,406	$806,421
TARS	Tarsus Pharmaceuticals, Inc.	+97,267	117,067	$7,368,196
ROIV	Roivant Sciences Ltd.	+91,958	220,126	$7,790,259
ERAS	Erasca, Inc.	+85,539	308,007	$5,642,687
LQDA	Liquidia Corp	+68,727	256,603	$20,458,957
ABVX	Abivax S.A.	+68,282	111,334	$14,836,368
No positions match the current search.

Trimmed

Positions the filer reduced

23 positions

Ticker	Company	Δ Shares	Shares	Value
CMPX	Compass Therapeutics, Inc.	−283,906	233,066	$510,414
AGIO	Agios Pharmaceuticals, Inc.	−152,647	56,900	$2,111,559
SLN	Silence Therapeutics plc	−96,652	60,107	$659,974
RLAY	Relay Therapeutics, Inc.	−79,516	178,222	$3,334,533
PCVX	Vaxcyte, Inc.	−78,650	29,800	$1,732,274
CRBP	Corbus Pharmaceuticals Holdings, Inc.	−64,255	21,432	$201,032
MIST	Milestone Pharmaceuticals Inc.	−63,100	270,233	$362,112
BCRX	Biocryst Pharmaceuticals Inc	−51,469	51,024	$510,240
IDYA	IDEAYA Biosciences, Inc.	−48,418	37,865	$1,411,228
CATX	Perspective Therapeutics, Inc.	−46,469	332,613	$1,134,210
LPCN	Lipocine Inc.	−46,100	78,842	$201,835
LRMR	Larimar Therapeutics, Inc.	−25,664	230,921	$704,309
FULC	Fulcrum Therapeutics, Inc.	−20,011	18,089	$66,205
ENTX	Entera Bio Ltd.	−14,188	191,354	$338,696
LONA	LeonaBio, Inc.	−10,523	154,153	$1,416,666
PMVP	PMV Pharmaceuticals, Inc.	−9,929	53,569	$71,782
SYRE	Spyre Therapeutics, Inc.	−6,390	13,300	$1,180,774
GLUE	Monte Rosa Therapeutics, Inc.	−5,730	16,800	$406,560
KRYS	Krystal Biotech, Inc.	−2,542	1,774	$659,342
AMLX	Amylyx Pharmaceuticals, Inc.	−2,131	14,540	$261,138
COGT	Cogent Biosciences, Inc.	−1,889	147,510	$5,708,637
ALKS	Alkermes plc.	−885	23,285	$1,220,134
ASND	Ascendis Pharma A/S	−310	11,869	$3,165,699
No positions match the current search.

New Positions

Positions the filer opened this quarter

23 positions

Ticker	Company	Shares	Value
MIRM	Mirum Pharmaceuticals, Inc.	110,393	$12,923,708
MANE	Veradermics, Inc	80,000	$9,835,200
STRO	Sutro Biopharma, Inc.	159,118	$5,282,717
EDIT	Editas Medicine, Inc.	1,330,500	$4,310,820
SGMT	Sagimet Biosciences Inc.	403,545	$3,119,402
PRAX	Praxis Precision Medicines, Inc.	7,540	$2,524,316
RLMD	Relmada Therapeutics, Inc.	348,265	$2,409,993
XENE	Xenon Pharmaceuticals Inc.	33,300	$2,009,988
SNDX	Syndax Pharmaceuticals Inc	77,930	$1,703,549
ANL	Adlai Nortye Group Ltd.	113,207	$1,301,880
OKUR	OnKure Therapeutics, Inc.	240,963	$1,098,791
SMMT	Summit Therapeutics Inc.	73,300	$1,067,981
ENGN	enGene Therapeutics Inc.	411,065	$711,142
NGNE	Neurogene Inc.	22,060	$693,787
IHI	iShares U.S. Medical Devices ETF	13,800	$681,858
OLMA	Olema Pharmaceuticals, Inc.	31,476	$393,764
CUE	Cue Biopharma, Inc.	10,702	$337,755
MBX	MBX Biosciences, Inc.	6,000	$331,200
VKTX	Viking Therapeutics, Inc.	7,404	$288,830
AZN	Astrazeneca PLC	1,400	$265,468
STOK	Stoke Therapeutics, Inc.	7,745	$253,416
WVE	Wave Life Sciences, Inc.	19,048	$110,668
QURE	uniQure N.V.	338	$15,568
No positions match the current search.

Sold Out

Positions the filer fully exited

25 positions

Ticker	Company	Shares	Value
TYRA	Tyra Biosciences, Inc.	195,685	$7,494,735
MLYS	Mineralys Therapeutics, Inc.	69,571	$1,884,678
REPL	Replimune Group, Inc.	120,400	$921,060
MAZE	Maze Therapeutics, Inc.	30,707	$916,603
CLYM	Climb Bio, Inc.	130,654	$894,979
CMPS	COMPASS Pathways plc	158,021	$873,856
DNLI	Denali Therapeutics Inc.	35,286	$677,491
UTHR	UNITED THERAPEUTICS Corp	1,128	$668,881
LLY	ELI LILLY & Co	720	$662,234
VSTM	Verastem, Inc.	123,400	$654,020
CNTX	Context Therapeutics Inc.	190,785	$499,856
NTLA	Intellia Therapeutics, Inc.	31,500	$403,830
EWTX	Edgewise Therapeutics, Inc.	11,701	$368,581
NKTR	Nektar Therapeutics	4,300	$309,385
SEPN	Septerna, Inc.	11,445	$275,023
OCUL	Ocular Therapeutix, Inc	31,296	$265,077
IRON	Disc Medicine, Inc.	3,231	$206,590
WHWK	Whitehawk Therapeutics, Inc.	54,296	$187,321
INBX	Inhibrx Biosciences, Inc.	2,482	$166,864
—		1,969	$165,730
PEPG	PepGen Inc.	59,500	$105,315
MGNX	Macrogenics Inc	13,387	$38,688
CGEM	Cullinan Therapeutics, Inc.	1,844	$26,203
—		2,072	$0
—		115,770	$0
No positions match the current search.

Portfolio Positions

Compact Export CSV View 13F filing

96 tracked positions · $610,242,510 total · filing declares 114 positions · $605,916,390 · as of Jun 30, 2026

All sectors Healthcare

Showing 1–50 of 96 positions by value · page 1 of 2

Ticker	Company	Type	Shares	Δ Shares	Value (USD)	% Δ Value	Held (qtrs)	Est. cost/share	% of Portfolio
CGON	CG Oncology, Inc. Healthcare	Added	1,886,236	+1,810,478	$134,017,067	+2513.8%	3	before history	21.96%
TNGX	Tango Therapeutics, Inc. Healthcare	Added	3,228,144	+2,726,132	$100,911,781	+860.9%	3	before history	16.54%
RVMD	Revolution Medicines, Inc. Healthcare	Added	242,029	+161,237	$45,327,190	+476.9%	3	before history	7.43%
PHVS	Pharvaris N.V. Healthcare	Added	774,501	+601,770	$26,782,243	+448.9%	3	before history	4.39%
LQDA	Liquidia Corp Healthcare	Added	256,603	+68,727	$20,458,957	+188.5%	3	before history	3.35%
ELVN	Enliven Therapeutics, Inc. Healthcare	Added	365,386	+201,356	$18,543,339	+188.4%	3	before history	3.04%
ABVX	Abivax S.A. Healthcare	Added	111,334	+68,282	$14,836,368	+209.5%	3	before history	2.43%
AVTX	Avalo Therapeutics, Inc. Healthcare	Added	770,765	+556,946	$14,243,736	+346.2%	3	before history	2.33%
MIRM	Mirum Pharmaceuticals, Inc. Healthcare	NEW	110,393	NEW	$12,923,708	NEW	1	$100.40	2.12%
ASMB	Assembly Biosciences, Inc. Healthcare	Added	433,147	+377,000	$11,902,879	+663.9%	3	before history	1.95%
IPSC	Century Therapeutics, Inc. Healthcare	Added	4,347,826	+1,400,000	$10,652,173	+59.9%	2	$2.16	1.75%
TSHA	Taysha Gene Therapies, Inc. Healthcare	Added	1,504,400	+878,692	$10,244,964	+266.3%	3	before history	1.68%
CYTK	Cytokinetics Inc Healthcare	Added	118,240	+56,971	$10,072,865	+149.4%	3	before history	1.65%
MANE	Veradermics, Inc Healthcare	NEW	80,000	NEW	$9,835,200	NEW	1	$93.67	1.61%
AVBP	ArriVent BioPharma, Inc. Healthcare	Added	246,606	+196,354	$8,567,092	+639.0%	2	$28.10	1.40%
ROIV	Roivant Sciences Ltd. Healthcare	Added	220,126	+91,958	$7,790,259	+119.4%	2	$27.30	1.28%
DMRA	Damora Therapeutics, Inc. Healthcare	Added	284,430	+183,182	$7,398,024	+182.1%	2	$24.74	1.21%
TARS	Tarsus Pharmaceuticals, Inc. Healthcare	Added	117,067	+97,267	$7,368,196	+430.5%	3	before history	1.21%
AXSM	Axsome Therapeutics, Inc. Healthcare	Added	28,826	+14,771	$7,055,740	+197.0%	3	before history	1.16%
DFTX	Definium Therapeutics, Inc. Healthcare	Added	148,647	+48,760	$6,992,354	+270.4%	2	$19.51	1.15%
DNTH	Dianthus Therapeutics, Inc. Healthcare	Added	64,723	+10,465	$6,309,197	+38.6%	3	before history	1.03%
XNCR	Xencor Inc Healthcare	Added	368,305	+288,305	$5,929,710	+514.6%	3	before history	0.97%
COGT	Cogent Biosciences, Inc. Healthcare	Reduced	147,510	-1,889	$5,708,637	−0.7%	3	before history	0.94%
ERAS	Erasca, Inc. Healthcare	Added	308,007	+85,539	$5,642,687	+56.8%	2	$12.51	0.92%
PTGX	Protagonist Therapeutics, Inc Healthcare	Added	45,400	+41,400	$5,565,132	+1220.0%	3	before history	0.91%
NERV	Minerva Neurosciences, Inc. Healthcare	Added	1,001,373	+752,897	$5,557,619	+271.2%	2	$5.50	0.91%
STRO	Sutro Biopharma, Inc. Healthcare	NEW	159,118	NEW	$5,282,717	NEW	1	$31.18	0.87%
EDIT	Editas Medicine, Inc. Healthcare	NEW	1,330,500	NEW	$4,310,820	NEW	1	$2.92	0.71%
CTMX	CytomX Therapeutics, Inc. Healthcare	Added	1,085,398	+714,000	$4,070,242	+133.2%	3	before history	0.67%
EPRX	Eupraxia Pharmaceuticals Inc. Healthcare	Added	610,785	+177,270	$4,037,288	+28.6%	2	$7.71	0.66%
RLAY	Relay Therapeutics, Inc. Healthcare	Reduced	178,222	-79,516	$3,334,533	+30.0%	3	before history	0.55%
CLDX	Celldex Therapeutics, Inc. Healthcare	Added	86,664	+57,364	$3,224,767	+247.0%	2	$30.60	0.53%
ASND	Ascendis Pharma A/S Healthcare	Reduced	11,869	-310	$3,165,699	+13.6%	3	before history	0.52%
SGMT	Sagimet Biosciences Inc. Healthcare	NEW	403,545	NEW	$3,119,402	NEW	1	$6.80	0.51%
SABS	SAB Biotherapeutics, Inc. Healthcare	Added	736,077	+636,077	$2,870,700	+649.5%	2	$3.76	0.47%
MDGL	Madrigal Pharmaceuticals, Inc. Healthcare	Added	4,973	+1,580	$2,670,252	+50.3%	3	before history	0.44%
ZLAB	Zai Lab Ltd Healthcare	Added	136,016	+58,158	$2,584,304	+76.5%	2	$19.06	0.42%
PRAX	Praxis Precision Medicines, Inc. Healthcare	NEW	7,540	NEW	$2,524,316	NEW	1	$316.56	0.41%
RLMD	Relmada Therapeutics, Inc. Healthcare	NEW	348,265	NEW	$2,409,993	NEW	1	$6.99	0.39%
AGIO	Agios Pharmaceuticals, Inc. Healthcare	Reduced	56,900	-152,647	$2,111,559	−70.2%	3	before history	0.35%
XENE	Xenon Pharmaceuticals Inc. Healthcare	NEW	33,300	NEW	$2,009,988	NEW	1	$55.52	0.33%
SVRA	Savara Inc Healthcare	Added	309,103	+13,415	$1,904,074	+17.9%	3	before history	0.31%
CCCC	C4 Therapeutics, Inc. Healthcare	Added	381,169	+324,093	$1,780,059	+1085.8%	2	$3.26	0.29%
PCVX	Vaxcyte, Inc. Healthcare	Reduced	29,800	-78,650	$1,732,274	−72.5%	3	before history	0.28%
SNDX	Syndax Pharmaceuticals Inc Healthcare	NEW	77,930	NEW	$1,703,549	NEW	1	$20.80	0.28%
CELC	Celcuity Inc. Healthcare	Added	16,252	+10,252	$1,700,284	+148.3%	3	before history	0.28%
ZNTL	Zentalis Pharmaceuticals, Inc. Healthcare	Added	317,600	+207,600	$1,540,360	+498.4%	2	$3.50	0.25%
GPCR	Structure Therapeutics Inc. Healthcare	Added	26,800	+17,800	$1,438,356	+231.6%	2	$52.37	0.24%
LONA	LeonaBio, Inc. Healthcare	Reduced	154,153	-10,523	$1,416,666	−16.3%	3	before history	0.23%
IDYA	IDEAYA Biosciences, Inc. Healthcare	Reduced	37,865	-48,418	$1,411,228	−50.9%	2	$33.55	0.23%

Showing the top 50 of 96 positions. Create a free account to see every position, past quarters, search, filters and CSV export.

Covers the securities this platform tracks: U.S.-listed common stock and the put/call positions reported on it. A 13F can also report security types outside that coverage — preferred shares, bonds, warrants, untracked share classes — so the filing's own declared total can exceed the figures above. The source filing is linked at the top of this table.